CVS Health stock has surged 24% over the past month following strong Q1 earnings that beat analyst expectations, with revenue up 6.2% to $100.4B and EPS up 62% to $2.30. The company raised full-year guidance and is benefiting from improved margins in its Aetna insurance segment and growth from Rite Aid store acquisitions. However, the company carries significant debt of $86.4B in long-term obligations, though it is gradually reducing overall leverage.

Humana Inc. experienced a data breach in August 2025 caused by a vendor's Oracle software vulnerability, exposing sensitive personal information including Social Security numbers, medical claims, and patient account data. Edelson Lechtzin LLP has launched a class action investigation to pursue legal remedies on behalf of affected individuals. Humana has reported no current evidence of identity theft or misuse from the incident.

CVS Health received positive news when Medicare finalized a 2.5% payment increase to providers, significantly better than the initially proposed 0.09% increase. This $13 billion boost to insurers like CVS's Aetna unit improves profitability outlook. Trading at 11x forward earnings compared to peers at 15-20x, CVS appears undervalued with potential to reach $90-$100 per share, supported by 3.4% dividend yield and expected earnings growth.

The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

The global dental insurance market is projected to grow from USD 118.77 billion in 2026 to USD 198.31 billion by 2032, with a CAGR of 8.72%. Growth is driven by digital transformation, evolving care models, and regulatory shifts. Key trends include provider consolidation, value-based care models, and increased investment in analytics and digital-first distribution channels.

DAV (Disabled American Veterans) announced the continuation of its partnership with Humana for the sixth consecutive year. Humana will expand its investment in DAV's mission to support veterans and their families by addressing challenges such as hunger, homelessness, financial strain, and transportation barriers. DAV assists over 1 million veterans annually in accessing benefits including health care, disability compensation, and employment resources.

Lifeward announced that Aetna has approved Medicare Advantage coverage for its ReWalk Personal Exoskeleton, joining Humana and UnitedHealthcare. The three insurers collectively represent approximately 16 million beneficiaries, significantly expanding access to the FDA-approved exoskeleton technology for individuals with spinal cord injuries.

Major M&A activity includes Mercedes-Benz planning to sell part of its Daimler Truck stake for €12 billion, Humana in advanced talks to acquire MaxHealth for ~$1 billion, ByteDance selling Mobile Legends creator for $6-7 billion, and Britney Spears selling her music catalog to Primary Wave. Warner Bros. Discovery faces activist opposition to its Netflix deal, while Baker Hughes considers divesting Waygate Technologies.

Humana stock fell to a 52-week low after the health insurer issued weak fiscal 2026 guidance, with adjusted EPS expected at $9 versus Wall Street's estimate of $11.92. While the company beat Q4 revenue expectations at $32.64 billion and reported solid operational performance, the significant earnings miss and membership declines overshadowed the positive results.

T-Mobile exceeded Q4 2025 earnings expectations with EPS of $2.14 and revenue of $24.33 billion, driven by industry-leading customer growth and network quality. The company projects 10% core adjusted EBITDA growth and $18.0-18.7 billion in adjusted free cash flow for 2026. Kraft Heinz faced sales decline but beat EPS expectations, while Humana exceeded revenue and EPS projections with strong Medicare Advantage growth.

Ten large-cap stocks experienced significant declines during the week of January 26-30, 2026. Unity Software fell 31.63% following CEO comments about world models amid competition from Google's Project Genie. Precious metals stocks including Hecla Mining (down 33.33%) and Coeur Mining (down 26.13%) declined after President Trump's nomination of Kevin Warsh for Fed Chair strengthened the dollar. Healthcare stocks UnitedHealth (down 17.87%) and Humana (down 26.07%) fell after analyst downgrades. Other notable losers included The Trade Desk (down 16.61%), First Majestic Silver (down 22.86%), Axon Enterprise (down 20.88%), Reddit (down 16.79%), and Regencell Bioscience (down 13.38%).

Michael Burry, famous for betting against the housing market, liquidated his UnitedHealth stake in Q3 2025 and rotated heavily into Molina Healthcare, calling it a 'generational buy.' While major insurers faced steep losses following a low 2027 Medicare rate proposal from CMS, Molina fared better than peers due to its 75% Medicaid revenue exposure and disciplined operations. Burry's contrarian bet appears to be paying off early in 2026.